{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:29:08Z","timestamp":1785281348744,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Arabian Gulf University R&EC"}],"content-domain":{"domain":["clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.clnesp.2016.03.078","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T13:40:08Z","timestamp":1462023608000},"page":"e33-e38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The high-molecular weight multimer form of adiponectin is a useful marker of polycystic ovary syndrome in Bahraini Arab women"],"prefix":"10.1016","volume":"13","author":[{"given":"Amina M.","family":"Al-Awadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Sarray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona R.","family":"Arekat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layal R.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeema","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim Y.","family":"Almawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2016.03.078_bib1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2016.03.078_bib2","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Androgen Excess Society: positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2016.03.078_bib3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"Task force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS Society: the androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clnesp.2016.03.078_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000341840","article-title":"Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome","volume":"40","author":"Carmina","year":"2013","journal-title":"Front Horm Res"},{"key":"10.1016\/j.clnesp.2016.03.078_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","article-title":"Molecular mechanisms of insulin resistance in polycystic ovary syndrome","volume":"12","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.clnesp.2016.03.078_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.ijo.0803793","article-title":"Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity","volume":"32","author":"Hung","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.clnesp.2016.03.078_bib7","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1210\/jc.2009-1557","article-title":"High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance","volume":"95","author":"O'Connor","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2016.03.078_bib8","first-page":"1636","article-title":"Normal basal and insulin stimulated fuel metabolism in lean women with the polycystic ovary syndrome","volume":"77","author":"Ovesen","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2016.03.078_bib9","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications FPR metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clnesp.2016.03.078_bib10","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2337\/dc05-1801","article-title":"Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome","volume":"29","author":"Hara","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnesp.2016.03.078_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/diabetes.55.01.06.db05-1105","article-title":"Adiponectin multimeric complexes and the metabolic syndrome trait cluster","volume":"55","author":"Lara-Castro","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.clnesp.2016.03.078_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4082\/kjfm.2011.32.4.243","article-title":"Adiponectin in women with polycystic ovary syndrome","volume":"32","author":"Shin","year":"2011","journal-title":"Kor J Fam Med"},{"key":"10.1016\/j.clnesp.2016.03.078_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","article-title":"Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"15","author":"Toulis","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.clnesp.2016.03.078_bib14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/jc.2009-1158","article-title":"Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-\u03b1","volume":"95","author":"Chazenbalk","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2016.03.078_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/met.2009.0036","article-title":"Decreased adiponectin levels in polycystic ovary syndrome, independent of body mass index","volume":"8","author":"Sharifi","year":"2010","journal-title":"Metabol Syndr Rel Disord"},{"key":"10.1016\/j.clnesp.2016.03.078_bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.metabol.2010.02.019","article-title":"Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome","volume":"60","author":"Wickham","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.clnesp.2016.03.078_bib17","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.fertnstert.2004.11.077","article-title":"Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome","volume":"83","author":"Ardawi","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clnesp.2016.03.078_bib18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2265.2004.02159.x","article-title":"Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome","volume":"61","author":"Spranger","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clnesp.2016.03.078_bib19","doi-asserted-by":"crossref","first-page":"18073","DOI":"10.1074\/jbc.M414231200","article-title":"Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes","volume":"280","author":"Xu","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clnesp.2016.03.078_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2265.2007.03015.x","article-title":"Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome","volume":"68","author":"Glintborg","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clnesp.2016.03.078_bib21","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/humrep\/deg353","article-title":"Serum adiponectin levels in women with polycystic ovary syndrome","volume":"18","author":"Panidis","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.clnesp.2016.03.078_bib22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/09513590600917943","article-title":"Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome","volume":"22","author":"Gulcelik","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.clnesp.2016.03.078_bib23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s00125-005-1758-7","article-title":"Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males","volume":"48","author":"Fisher","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2016.03.078_bib24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.fertnstert.2007.04.046","article-title":"Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action","volume":"89","author":"Aroda","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clnesp.2016.03.078_bib25","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1210\/jc.2007-2759","article-title":"Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition","volume":"93","author":"Barber","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2016.03.078_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diabetes.51.1.7","article-title":"Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes","volume":"51","author":"McGarry","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.clnesp.2016.03.078_bib27","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1210\/jc.2006-1158","article-title":"Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese Americans","volume":"91","author":"Nakashima","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2016.03.078_bib28","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.numecd.2009.05.009","article-title":"The high molecular weight (HMW) form of adiponectin is a significant surrogate marker for the prediction of type 2 diabetes mellitus in the Japanese population","volume":"20","author":"Satoh","year":"2010","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.clnesp.2016.03.078_bib29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1210\/jc.2010-1290","article-title":"Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance","volume":"96","author":"Manneras-Holm","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2016.03.078_bib30","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1210\/jc.2002-022033","article-title":"Adiponectin levels in women with polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2016.03.078_bib31","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/humrep\/del146","article-title":"Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study","volume":"21","author":"Escobar-Morreale","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.clnesp.2016.03.078_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/09513590701260169","article-title":"The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome","volume":"23","author":"Bik","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.clnesp.2016.03.078_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000086273","article-title":"Determinants of circulating adiponectin in women with polycystic ovary syndrome","volume":"60","author":"Vrb\u00edkov\u00e1","year":"2005","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.clnesp.2016.03.078_bib34","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1210\/jc.2005-1002","article-title":"Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance","volume":"90","author":"Puder","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457716301784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457716301784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T04:03:14Z","timestamp":1718510594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457716301784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":34,"alternative-id":["S2405457716301784"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2016.03.078","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The high-molecular weight multimer form of adiponectin is a useful marker of polycystic ovary syndrome in Bahraini Arab women","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2016.03.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}